![]()
| 27 Jul 2022 | TPTXTurning Point Therapeutics Inc | Paolo Tombesi EVP and Chief Financial Officer | Sale | 1,183 | $74.94 | $88,654 27 Jul 2022 | 28,700 | ↗ |
| 9 Feb 2022 | TPTXTurning Point Therapeutics Inc | Siegfried Reich EVP and Chief Scientific Officer | Sale | 397 | $36.30 | $14,411 9 Feb 2022 | 3,448 | ↗ |
| 9 Feb 2022 | TPTXTurning Point Therapeutics Inc | Andrew John Partridge EVP and Chief Commercial Officer | Sale | 221 | $36.30 | $8,022 9 Feb 2022 | 22,078 | ↗ |
| 9 Feb 2022 | TPTXTurning Point Therapeutics Inc | Annette North EVP and General Counsel | Sale | 669 | $36.30 | $24,285 9 Feb 2022 | 11,696 | ↗ |
| 9 Feb 2022 | TPTXTurning Point Therapeutics Inc | Mohammad Hirmand EVP and Chief Medical Officer | Sale | 669 | $36.30 | $24,285 9 Feb 2022 | 6,838 | ↗ |
| 9 Feb 2022 | TPTXTurning Point Therapeutics Inc | Athena Countouriotis President and CEO | Sale | 2,971 | $36.30 | $107,847 9 Feb 2022 | 47,930 | ↗ |
| 30 Aug 2021 | TPTXTurning Point Therapeutics Inc | Annette North EVP and General Counsel | Option | 10,000 | $17.00 | $170,000 30 Aug 2021 | 22,365 | ↗ |
| 14 Jul 2021 | TPTXTurning Point Therapeutics Inc | Andrew John Partridge EVP and Chief Commercial Officer | Sale | 1,869 | $74.90 | $139,988 14 Jul 2021 | 21,767 | ↗ |
| 21 Jun 2021 | TPTXTurning Point Therapeutics Inc | Mark J Alles Director | Buy | 2,000 | $81.34 | $162,680 21 Jun 2021 | 2,000 | ↗ |
| 15 Jun 2021 | TPTXTurning Point Therapeutics Inc | Annette North EVP and General Counsel | Option | 15,000 | $17.00 | $255,000 15 Jun 2021 | 27,365 | ↗ |
| 6 May 2021 | TPTXTurning Point Therapeutics Inc | Annette North EVP and General Counsel | Option | 5,882 | $17.00 | $99,994 6 May 2021 | 12,365 | ↗ |
| 22 Mar 2021 | TPTXTurning Point Therapeutics Inc | Brian Lee Baker SVP of Finance and Admin. | Option | 28,435 | $4.67 | $132,791 22 Mar 2021 | 32,551 | ↗ |
| 8 Mar 2021 | TPTXTurning Point Therapeutics Inc | Annette North EVP and General Counsel | Option | 20,000 | $17.00 | $340,000 8 Mar 2021 | 26,483 | ↗ |
| 4 Mar 2021 | TPTXTurning Point Therapeutics Inc | Siegfried Reich EVP and Chief Scientific Officer | Option | 35,550 | $51.28 | $1,823,004 4 Mar 2021 | 39,395 | ↗ |
| 9 Feb 2021 | TPTXTurning Point Therapeutics Inc | Athena Countouriotis President and CEO | Option | 60,000 | $3.20 | $192,000 9 Feb 2021 | 59,137 | ↗ |
| 1 Feb 2021 | TPTXTurning Point Therapeutics Inc | Annette North EVP and General Counsel | Option | 25,000 | $17.00 | $425,000 1 Feb 2021 | 9,016 | ↗ |
| 1 Feb 2021 | TPTXTurning Point Therapeutics Inc | Yi Larson EVP and Chief Financial Officer | Option | 30,000 | $54.03 | $1,620,900 1 Feb 2021 | 17,002 | ↗ |
| 7 Jan 2021 | TPTXTurning Point Therapeutics Inc | Brian Lee Baker SVP of Finance and Admin. | Sale | 31,238 | $122.26 | $3,819,158 7 Jan 2021 | 1,008 | ↗ |
| 4 Jan 2021 | TPTXTurning Point Therapeutics Inc | Mohammad Hirmand EVP and Chief Medical Officer | Sale | 10,300 | $120.43 | $1,240,429 4 Jan 2021 | 284 | ↗ |
| 9 Jun 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 9,500 | $65.81 | $625,195 9 Jun 2020 | 540,383 | ↗ |
| 4 Jun 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 55,500 | $64.16 | $3,560,880 4 Jun 2020 | 549,883 | ↗ |
| 21 May 2020 | TPTXTurning Point Therapeutics Inc | Plc Gsk Director | Buy | 83,333 | $60.00 | $4,999,980 21 May 2020 | 2,253,660 | ↗ |
| 21 May 2020 | TPTXTurning Point Therapeutics Inc | Simeon George Director | Buy | 83,333 | $60.00 | $4,999,980 21 May 2020 | 2,253,660 | ↗ |
| 21 May 2020 | TPTXTurning Point Therapeutics Inc | Athena Countouriotis President and CEO | Buy | 4,166 | $60.00 | $249,960 21 May 2020 | 26,872 | ↗ |
| 19 May 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 21,000 | $59.18 | $1,242,780 19 May 2020 | 605,383 | ↗ |
| 8 May 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 11,500 | $53.86 | $619,390 8 May 2020 | 626,383 | ↗ |
| 5 May 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 55,500 | $53.27 | $2,956,485 5 May 2020 | 637,883 | ↗ |
| 22 Apr 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 21,000 | $51.57 | $1,082,970 22 Apr 2020 | 693,383 | ↗ |
| 9 Apr 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 12,208 | $47.60 | $581,101 9 Apr 2020 | 714,383 | ↗ |
| 6 Apr 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 55,500 | $44.87 | $2,490,285 6 Apr 2020 | 726,591 | ↗ |
| 26 Mar 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 11,500 | $46.03 | $529,345 26 Mar 2020 | 782,091 | ↗ |
| 23 Mar 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 31,792 | $43.11 | $1,370,553 23 Mar 2020 | 793,591 | ↗ |
| 10 Mar 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 44,000 | $40.84 | $1,796,960 10 Mar 2020 | 825,383 | ↗ |
| 24 Feb 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 21,000 | $52.16 | $1,095,360 24 Feb 2020 | 869,383 | ↗ |
| 13 Feb 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 11,500 | $61.84 | $711,160 13 Feb 2020 | 781,219 | ↗ |
| 10 Feb 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 55,500 | $64.03 | $3,553,665 10 Feb 2020 | 792,719 | ↗ |
| 27 Jan 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 21,000 | $58.25 | $1,223,250 27 Jan 2020 | 848,219 | ↗ |
| 15 Jan 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 11,500 | $53.12 | $610,880 15 Jan 2020 | 869,219 | ↗ |
| 10 Jan 2020 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 55,500 | $54.70 | $3,035,850 10 Jan 2020 | 880,719 | ↗ |
| 18 Dec 2019 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 48,500 | $60.92 | $2,954,620 18 Dec 2019 | 936,219 | ↗ |
| 13 Dec 2019 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 41,500 | $58.95 | $2,446,425 13 Dec 2019 | 984,719 | ↗ |
| 10 Dec 2019 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 34,500 | $53.88 | $1,858,860 10 Dec 2019 | 1,026,219 | ↗ |
| 5 Dec 2019 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Sale | 118,500 | $51.77 | $6,134,745 5 Dec 2019 | 1,060,719 | ↗ |
| 10 Sep 2019 | TPTXTurning Point Therapeutics Inc | Plc Gsk Director | Buy | 177,777 | $45.00 | $7,999,965 10 Sep 2019 | 2,170,327 | ↗ |
| 10 Sep 2019 | TPTXTurning Point Therapeutics Inc | Simeon George Director | Buy | 177,777 | $45.00 | $7,999,965 10 Sep 2019 | 2,170,327 | ↗ |
| 10 Sep 2019 | TPTXTurning Point Therapeutics Inc | Yi Larson EVP and Chief Financial Officer | Buy | 2,222 | $45.00 | $99,990 10 Sep 2019 | 2,222 | ↗ |
| 10 Sep 2019 | TPTXTurning Point Therapeutics Inc | Athena Countouriotis President and CEO | Buy | 10,000 | $45.00 | $450,000 10 Sep 2019 | 22,000 | ↗ |
| 27 Jun 2019 | TPTXTurning Point Therapeutics Inc | Jingrong Jean Cui Director | Option | 109,164 | $4.98 | $543,637 27 Jun 2019 | 890,383 | ↗ |
| 14 May 2019 | TPTXTurning Point Therapeutics Inc | Asset Management, Lp Chen B... | Option | 23,268 | $2.19 | $50,957 14 May 2019 | 3,122,367 | ↗ |
| 22 Apr 2019 | TPTXTurning Point Therapeutics Inc | Asset Management, Lp Chen B... | Buy | 400,000 | $18.00 | $7,200,000 22 Apr 2019 | 3,099,099 | ↗ |
